Bloomberg - Evening Briefing - The Covid pill dilemma

Bloomberg’s Evening Briefing

The U.S. has cleared its first two Covid-19 treatment pills. Now comes the hard part: deciding who should get one. Merck’s molnupiravir was authorized Thursday by the Food and Drug Administration for use in some infected adults at high risk of severe illness. The U.S. will soon have 3 million courses of it available. Meanwhile, Pfizer’s Paxlovid, authorized earlier this week, showed stronger clinical trial data. But it will only be available in limited quantities at first, as Pfizer takes months to ramp up manufacturing. Regulators are signaling they prefer Pfizer’s pill, but concede Merck’s drug is better than nothing. Regardless, availability may depend on which state you live in.

Bloomberg is tracking the coronavirus pandemic and the progress of global vaccination efforts.

Here are today’s top stories

The omicron variant’s case rate has now exceeded the worst days of the first delta-fueled wave, and more cities and countries are imposing precautions. But there’s more research showing it to be less severe than previous mutations. That said, two doses and a booster of the vaccine most widely used around the world isn’t enough to fight off omicron. China’s Sinovac shot didn’t produce sufficient levels of neutralizing antibodies, research found. Another study however showed a third dose of AstraZeneca’s vaccine, like that of Moderna and Pfizer-BioNTech, significantly boosts protection against the variant. Here’s the latest on the pandemic

China formed a rare-earths giant by merging some key producers, creating a behemoth that will strengthen its control over the global industry it has dominated for decades.

The U.S. has been trying to develop more rare-earth mining capacity in the face of Chinese domination of the industry. Above, the Mountain Pass mine operated by MP Materials in California. Photographer: Joe Buglewicz/Bloomberg

That crazy stock market is back to breaking records again. Equities rose to a new high on speculation the ongoing recovery from last year’s pandemic recession can survive the omicron wave. On Thursday, electric-vehicle startup Nikola surged amid optimism about deliveries. U.S.-listed shares of JD.com sank on news that Tencent planned to distribute $16 billion of its stock as a dividend. Here’s your markets wrap.

Regulators rejected a pair of proposals to offer physically-backed Bitcoin exchange-traded funds, handing crypto enthusiasts a bag of coal ahead of the Christmas holiday.

U.S. President Joe Biden indicated he would support changing Senate filibuster rules to enact voting rights legislation as a last resort, though currently there aren’t enough votes to do so. The landmark bill is almost universally opposed by Senate Republicans and even a few conservative Democrats. With Republicans rewriting state laws across the country to restrict voting access while empowering GOP officials in states they control to oversee election results, democracy advocates are warning that the fairness of many American elections may be in jeopardy.

Biden on Thursday signed into law a bill banning goods from China’s Xinjiang region unless companies can prove they aren’t made with forced labor. The crackdown on this key link in the global supply chain comes in reaction to Beijing’s longstanding oppression and mass imprisonment of the nation’s Muslim Uyghur minority.

Inflation in the U.S. has been rising at the fastest pace in decades. But ask consumers across political parties where prices are headed in the near future, and you’ll get entirely different outlooks.

What you’ll need to know tomorrow

A World’s Best Bartender Knows Holiday Drinks

If you’re making a list of people you most want to mix you a drink this holiday season, Lynnette Marrero should be at the top. Marrero is the winner of the Altos Bartenders’ Bartender Award, part of the World’s Best Bars celebration, which took place in London on Dec. 7. The award is the result of votes from the drinkmakers at the top 50 bars. Here’s what’s at the top of her list.

Older messages

Omicron is looking weaker

Thursday, December 23, 2021

Bloomberg's Evening Briefing View in browser Bloomberg The omicron variant of Covid-19 may be less likely to land patients in the hospital than the delta strain, according to three studies of

Covid pills are coming

Tuesday, December 21, 2021

Bloomberg's Evening Briefing View in browser Bloomberg The US Food and Drug Administration is poised to authorize a pair of pills from Pfizer and Merck to treat Covid-19, a potential milestone in

The Manchin downgrade

Tuesday, December 21, 2021

Bloomberg's Evening Briefing View in browser Bloomberg A third dose of Moderna's Covid-19 vaccine significantly increased antibody levels against the omicron variant, the company said, adding

America’s omicron disconnect

Saturday, December 18, 2021

Bloomberg's Weekend Reading View in browser Bloomberg Follow Us Get the newsletter Just when it seemed Americans could start half-thinking about a return to normalcy, the omicron variant presented

Omicron spikes

Friday, December 17, 2021

Bloomberg's Evening Briefing View in browser Bloomberg Around every corner there seems to be new research on this latest, still-mysterious variant of the coronavirus. Scientists are banging away

You Might Also Like

🇨🇳 The US is out, China is in

Tuesday, March 11, 2025

Citigroup's forecast for US and Chinese stocks, Lego stacked bricks, and Boeing's investigation | Finimize Hi Reader, here's what you need to know for March 12th in 3:10 minutes. Citigroup

The Under-the-Radar Threat to Your Retirement

Tuesday, March 11, 2025

Nearly half of older adults are burdened by bad debt ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

15 Years Since We Bought Our Toxic Asset

Tuesday, March 11, 2025

In a new Planet Money plus episode, former Planet Money hosts David Kestenbaum and Chana Joffe-Walt look back at a pioneering series that sought to explain a major source of the 2008 financial crisis.

👋 Investors ditched the S&P 500

Monday, March 10, 2025

The US president didn't rule out a recession, but TSMC eased some of investors' other worries | Finimize Hi Reader, here's what you need to know for March 11th in 3:07 minutes. TSMC's

💳 Find a new credit card

Monday, March 10, 2025

Let's get those rewards ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

Text and Telos

Monday, March 10, 2025

Plus! Diff Jobs; Scaling; Retail Investors; Comparative Advantage; Transaction Costs and Corporate Structure; DeepSeek Governance Text and Telos By Byrne Hobart • 10 Mar 2025 View in browser View in

Longreads + Open Thread

Saturday, March 8, 2025

Personal Essays, Lies, Popes, GPT-4.5, Banks, Buy-and-Hold, Advanced Portfolio Management, Trade, Karp Longreads + Open Thread By Byrne Hobart • 8 Mar 2025 View in browser View in browser Longreads

💸 A $24 billion grocery haul

Friday, March 7, 2025

Walgreens landed in a shopping basket, crypto investors felt pranked by the president, and a burger made of skin | Finimize Hi Reader, here's what you need to know for March 8th in 3:11 minutes.

The financial toll of a divorce can be devastating

Friday, March 7, 2025

Here are some options to get back on track ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

Too Big To Fail?

Friday, March 7, 2025

Revisiting Millennium and Multi-Manager Hedge Funds ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏